Cardiorespiratory fitness assessment improves accuracy of health predictions

Fitness levels predict health and longevity and should be incorporated as a vital assessment tool in routine clinical practice, report scientists in a new study published in Mayo Clinic Proceedings


Rochester, MN, April 30, 2020

According to a new study in Mayo Clinic Proceedings, published by Elsevier, taking cardiorespiratory fitness (CRF) into account along with traditional risk factors such as age, sex, blood pressure, cholesterol, and smoking, improves the accuracy of mortality risk assessment.

“We found that within a contemporary adult UK population with a varied and relatively low pre-test risk profile, greater CRF was strongly associated with a lower risk of mortality. The findings enabled new insights into the incremental prognostic value of a CRF evaluation,” explained lead investigator Jari A. Laukkanen, MD, PhD, Cardiologist, Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland. “The predictive accuracy of CRF levels was even more evident when factored in with traditional risk factors such as age, sex, blood pressure, cholesterol and smoking.”

Although conventional risk factors such as age, sex, blood pressure, cholesterol, and smoking can significantly contribute to the risk of vascular disease and mortality, these established risk factors are often absent in a large proportion of cardiovascular disease patients. This contributes to difficulties in identifying individuals at increased risk for vascular disease and/or death.

CRF is recognized as an important marker of both functional ability and mortality and a wealth of literature shows this measure to be inversely and independently associated with vascular disease and mortality. However, physicians do not routinely assess fitness – in either general or specialized clinical settings -- when testing for traditional risk factors.

This study was based on data from the large-scale UK Biobank Study, which gathered information on close to 60,000 participants aged 40-69 years. It assessed CRF using submaximal exercise testing in the form of a six-minute stationary bicycle protocol. This protocol is easily available, has a good safety profile, reliability, and validity.The investigators evaluated the impact of the CRF assessment against and in conjunction with risk factors typically measured in clinical practice. Investigators used mortality data from the National Health Service Information Centre (England and Wales) and the Scottish Morbidity Record, from which they were able to classify the causes of death.

This is one of the first large scale population-based studies showing that risk prediction can be improved in a pre-screened relatively low risk population by adding information on CRF, estimated on the basis of a submaximal exercise test, to conventional cardiovascular risk factors. During a median follow-up of 5.8 years, 936 deaths occurred within the study group.

“Do we really need to make CRF evaluations a standard part of a medical exam? Based on what we learned, the answer is ‘yes.’ Our findings clearly validate them as vital clinical risk predictors in conjunction with the other factors,” noted Dr. Laukkanen. “Submaximal exercise testing in order to factor in CRF levels with conventional risk factors should be routinely used by clinicians to determine whether high-risk patients need additional interventions.”

In an accompanying editorial, Carl J. Lavie, MD, Cardiologist, John Ochsner Heart and Vascular Institute, Ochsner Clinical School - University of Queensland School of Medicine, New Orleans, LA, USA, and co-authors observed that “Certainly, numerous studies show the powerful impact of CRF in predicting risk. Although the gold standard assessment of CRF is cardiopulmonary exercise testing and using gas exchange to measure peak oxygen consumption, many clinicians do not have easy access to such testing, and neither do they have the equipment and personnel to monitor these tests, not to mention the moderate expense of this testing. The unique aspect of the present UK Biobank study was using a submaximal six-minute bicycle test in a very large cohort to assess CRF and mortality combined with established CVD risk factors.”

CRF is an index of habitual physical activity, particularly aerobic exercise. Good CRF helps to ward off chronic diseases, provides general wellbeing, and reduces the risk of premature death. In addition to good nutrition and, adequate rest and relaxation, individuals can improve their fitness levels by undertaking regular exercise. Fitness and exercise are potential ways to avoid daily stress, which can take a substantial toll on human health.

“We need to do a better job promoting physical activity and exercise training (aerobic and resistance) throughout the healthcare system, schools, the workplace, and society for the primary and secondary prevention of cardiovascular disease. The long-term health of our populations will depend on the success of these efforts,” commented Dr. Lavie and co-authors.

---

Notes for editors
The article is “Prognostic Relevance of Cardiorespiratory Fitness as Assessed by Submaximal Exercise Testing for All-Cause Mortality: A UK Biobank Prospective Study,” by Jari A. Laukkanen, MD, PhD; Setor K. Kunutsor, MD, PhD; Thomas Yates, PhD; Peter Willeit, MD, PhD; Urho M. Kujala, MD, PhD; Hassan Khan, MD, PhD; and Francesco Zaccardi, MD, PhD(https://doi.org/10.1016/j.mayocp.2019.12.030).

The editorial is “UK Biobank Contributes to Aerobic and Muscle Fitness Research,” by Carl J. Lavie, MD; Duck-chul Lee, PhD; and Francisco B. Ortega, PhD (https://doi.org/10.1016/j.mayocp.2020.03.019). They appear in Mayo Clinic Proceedings, volume 95, issue 5 (May 2020) published by Elsevier.

Full text of the article is available to credentialed journalists upon request. Contact Brittney Binns at +1 215 297 3278 or mcpmedia@elsevier.com to obtain copies.

An accompanying video is posted here.

Journalists wishing to interview the study authors should contact Jari A. Laukkanen at +358 50 5053013; jariantero.laukkanen@uef.fi or Ulla Kaltiala, Communications Officer, University of Eastern Finland, at +358 40 745 6463; ulla.kaltiala@uef.fi. To reach the editorial’s authors for comment, contact Carl J. Lavie at +1 504 842 1281; clavie@ochsner.org.

About Mayo Clinic Proceedings
The flagship journal of Mayo Clinic and one of the premier peer-reviewed clinical journals in general medicine, Mayo Clinic Proceedings is among the most widely read and highly cited scientific publications for physicians, with a circulation of approximately 125,000. While the Journal is sponsored by Mayo Clinic, it welcomes submissions from authors worldwide, publishing articles that focus on clinical medicine and support the professional and educational needs of its readers. www.mayoclinicproceedings.org

About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader in medical care, research, and education for people from all walks of life. For more information visit www.mayoclinic.org/about and www.mayoclinic.org/news.

About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com

Media contact
Brittney Binns
Elsevier
+1 215 297 3278
mcpmedia@elsevier.com